Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
暂无分享,去创建一个
P. Leavey | J. Healey | M. Devidas | M. Gebhardt | M. Bernstein | E. Perlman | C. Arndt | A. Goorin | H. Grier | M. Krailo | P. Dickman | J. Miser | N. Marina | R. Womer | S. Sailer | R. Shamberger | James S. Meyer | K. Marcus | Chenguang Wang | L. Granowetter
[1] O. Delattre,et al. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] E. Pignotti,et al. Second Malignancy in 597 Patients With Ewing Sarcoma of Bone Treated at a Single Institution With Adjuvant and Neoadjuvant Chemotherapy Between 1972 and 1999 , 2005, Journal of pediatric hematology/oncology.
[3] Ø. Borgan. The Statistical Analysis of Failure Time Data , 2003 .
[4] N. Tarbell,et al. Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall: Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy , 2003, Annals of surgery.
[5] S. Donaldson,et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. , 2003, The New England journal of medicine.
[6] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[7] T. Triche,et al. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.
[8] A. Olshan,et al. Second malignancies in very-long-term survivors of childhood cancer. , 1992, The American journal of medicine.
[9] R. Simon,et al. Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. , 1991, Journal of the National Cancer Institute.
[10] M. Smith. The impact of doxorubicin dose intensity on survival of patients with Ewing's sarcoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] W. Hryniuk,et al. The calculation of received dose intensity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G. Frezza,et al. Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients. , 1990, International journal of radiation oncology, biology, physics.
[13] E. Gehan,et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] G. Bacci,et al. Neoadjuvant Chemotherapy for Localized Ewing's Sarcoma of the Extremities: Preliminary Results of a Protocol Which uses Surgery (Alone or Followed by Radiotherapy) for Local Control , 1989, Tumori.
[15] D M Green,et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1987, The New England journal of medicine.
[16] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[17] R. Johnson,et al. Past failures and future possibilities in Ewing's sarcoma: Experimental and preliminary clinical results , 1969, Cancer.
[18] M. Samuels,et al. Cyclophosphamide in the management of Ewing's sarcoma , 1967, Cancer.
[19] M. Alpert,et al. Five-year survival of patients with Ewing's sarcoma. , 1967, Surgery, gynecology & obstetrics.
[20] M. B. Coventry,et al. Ewing's sarcoma. A critical analysis of 165 cases. , 1961, The Journal of bone and joint surgery. American volume.
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[22] F. Askin,et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. , 2007, Blood.
[23] M. Link,et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] W. Winkelmann,et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6‐year experience of a European cooperative trial , 1988, Cancer.
[25] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[26] G. Mierau. Extraskeletal Ewing's sarcoma (peripheral neuroepithelioma). , 1985, Ultrastructural pathology.